In a recent update, RBC Capital analysts have maintained their Outperform rating on Boston Scientific (NYSE:BSX) shares, with ...

TD Cowen reiterated a Buy rating for Boston Scientific (NYSE:BSX) stock, maintaining a price target of $110.00. The stock, currently trading at $98.78, has shown remarkable momentum, reaching new ...

Boston Scientific Corp (BSX) stock saw a modest uptick, ending the day at $98.17 which represents a slight increase of $1.28 or 1.32% from the prior close of $96.89. The stock opened at $97.03 and ...

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Inspire Medical Systems (INSP – Research Report) yesterday and set a price ...

In a report released yesterday, Shagun Singh Chadha from RBC Capital reiterated a Buy rating on Boston Scientific (BSX – Research Report), with ...

Capital Investment Advisors LLC raised its holdings in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 12.2% in ...

Shares of Boston Scientific Corp. BSX advanced 1.30% to $96.89 Wednesday, on what proved to be an all-around great trading ...

After a busy 2024, experts called out competition in soft tissue robotics, uncertainty from a Trump White House and continued ...

International Assets Investment Management LLC lowered its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 95.3 ...

The upgrade follows detailed guidance from AT&T’s recent Capital Markets Day, where the company outlined plans to eliminate legacy costs and leverage fiber investments. RBC Capital analysts ...

according to RBC Capital Markets. In its recent report, RBC reveals that “modest downward revisions have returned to bottom-up consensus S&P 500 EPS forecasts as the new year has gotten underway ...